Joshua Dean

Joshua Dean supports the procurement mission of the W4PZ USA Medical Research Acquisition Act under the Department of the Army, facilitating critical acquisitions that translate biomedical innovation into field-deployable medical capabilities for warfighter readiness. Though his formal title is not specified, his role centers on managing research and development contracts in life sciences, clinical diagnostics, and biotechnology, ensuring alignment with the agency’s mandate to advance military medical science. He typically handles competitive solicitations under FAR Part 35 and other R&D-specific authorities, working closely with scientific teams to define technical requirements and evaluate proposer capabilities for high-stakes, mission-critical projects. Dean’s contractor relationships span a diverse ecosystem of research institutions, biotech firms, and specialized laboratories, with a strong emphasis on academic and non-traditional defense contractors capable of rapid prototyping and translational research. He engages with vendors possessing deep expertise in molecular diagnostics, point-of-care testing, and bioanalytical systems, fostering partnerships that bridge the gap between laboratory discovery and operational deployment. His procurement approach prioritizes technical merit, agility, and scalability, often leveraging Other Transaction Authorities (OTAs) and Broad Agency Announcements (BAAs) to accelerate innovation. Dean exhibits a clear preference for open competition, with 80% of acquisitions conducted without set-asides, yet he maintains a consistent 20% commitment to Total Small Business Set-Asides under FAR 19.5, supporting small firms with proven capabilities in life sciences R&D. While he does not favor specific socioeconomic categories like 8(a) or HUBZone exclusively, his portfolio regularly includes small businesses with niche expertise in biotechnology and medical laboratory services. His primary NAICS focus is 541715 and 541714, reflecting deep specialization in physical and life sciences research, with secondary emphasis on medical laboratories and hazardous waste handling for biomedical materials. Dean’s procurement portfolio centers on diagnostic platforms, biosensors, therapeutic development tools, and analytical systems essential to battlefield medicine and force health protection.